Clinical development of listeria monocytogenes-based immunotherapies

Seminars in Oncology

Volumn 39, Issue 3, 2012, Pages 311-322

  Le, Dung T ^a   Dubenksy, Thomas W ^b   Brockstedt, Dirk G ^b  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b Aduro BioTech Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMPICILLIN; ANTINEOPLASTIC AGENT; ANZ 100; BACTERIAL VACCINE; BACTERIAL VECTOR; BMB 54; BMB 72; CRS 207; CYCLOPHOSPHAMIDE; GLYCOPROTEIN P 15095; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IPILIMUMAB; ISOPROPYL THIOGALACTOSIDE; LH 1169; LOVAXIN C; MESOTHELIN; PATTERN RECOGNITION RECEPTOR; UNCLASSIFIED DRUG;

ADAPTIVE IMMUNITY; ANTIGEN EXPRESSION; ANTINEOPLASTIC ACTIVITY; ARTICLE; AUXOTROPHIC MUTANT; BACTERIAL CHROMOSOME; BACTERIAL STRAIN; BACTERIAL VIRULENCE; CANCER IMMUNOTHERAPY; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR DISTRIBUTION; CELLULAR IMMUNITY; CHILL; COLONY FORMING UNIT; CROSS LINKING; CYTOKINE RELEASE; DRUG DOSE ESCALATION; DRUG EFFICACY; DRUG FEVER; DRUG SAFETY; DRUG TOLERABILITY; FLU LIKE SYNDROME; HEADACHE; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; IMMUNOGENICITY; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; IMMUNOREGULATION; IMMUNOSTIMULATION; INNATE IMMUNITY; LISTERIA MONOCYTOGENES; LIVER METASTASIS; LOW DRUG DOSE; LYMPHOCYTOPENIA; MAXIMUM TOLERATED DOSE; MELANOMA; MICROBIAL ATTENUATION; MUSCULOSKELETAL PAIN; MYCOBACTERIUM BOVIS; NAUSEA AND VOMITING; NONHUMAN; PANCREAS CANCER; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; SALMONELLA TYPHI; SINGLE DRUG DOSE; STREPTOCOCCUS PYOGENES; TACHYCARDIA; TREATMENT DURATION; TREATMENT RESPONSE; UTERINE CERVIX CARCINOMA; VIBRIO CHOLERAE;

EID: 84861133805     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.seminoncol.2012.02.008     Document Type: Article

References (81)

1. P.D. Greenberg Adoptive T cell therapy of tumors: mechanisms operative in the recognition and elimination of tumor cells Adv Immunol 49 1991 281 355
2. F.R. Appelbaum Graft versus leukemia (GVL) in the therapy of acute lymphoblastic leukemia (ALL) Leukemia 11 Suppl 4 1997 S15 S17
3. T. Boon, P.G. Coulie, B.J. Van den Eynde, P. van der Bruggen Human T cell responses against melanoma Annu Rev Immunol 24 2006 175 208
4. T. Boon, J.C. Cerottini, B. Van den Eynde, P. van der Bruggen, A. Van Pel Tumor antigens recognized by T lymphocytes Annu Rev Immunol 12 1994 337 365 (Pubitemid 24140418)
5. P.G. Coulie, V. Karanikas, C. Lurquin Cytolytic T-cell responses of cancer patients vaccinated with a MAGE antigen Immunol Rev 188 2002 33 42 (Pubitemid 35398863)
6. M.L. Disis, T.A. Gooley, K. Rinn Generation of T-cell immunity to the HER-2/neu protein after active immunization with HER-2/neu peptide-based vaccines J Clin Oncol 20 2002 2624 2632 (Pubitemid 34575634)
7. Y. Kawakami, S.A. Rosenberg Immunobiology of human melanoma antigens MART-1 and gp100 and their use for immuno-gene therapy Int Rev Immunol 14 1997 173 192 (Pubitemid 27185947)
8. M.A. Cheever, J.P. Allison, A.S. Ferris The prioritization of cancer antigens: a national cancer institute pilot project for the acceleration of translational research Clin Cancer Res 15 2009 5323 5337
9. A.M. Thomas, L.M. Santarsiero, E.R. Lutz Mesothelin-specific CD8(+) T cell responses provide evidence of in vivo cross-priming by antigen-presenting cells in vaccinated pancreatic cancer patients J Exp Med 200 2004 297 306 (Pubitemid 39031249)
10. S. Lucas, P.G. Coulie About human tumor antigens to be used in immunotherapy Semin Immunol 20 2008 301 307
11. S. Brandau, H. Suttmann Thirty years of BCG immunotherapy for non-muscle invasive bladder cancer: a success story with room for improvement Biomed Pharmacother 61 2007 299 305 (Pubitemid 47189735)
12. + T-cell memory Nat Rev Immunol 8 2008 107 119 (Pubitemid 351161304)
13. L.G. Tilney, D.A. Portnoy Actin filaments and the growth, movement, and spread of the intracellular bacterial parasite, Listeria monocytogenes J Cell Biol 109 1989 1597 1608
14. +-T-cell potency during bacterial infection Infect Immun 74 2006 6387 6397 (Pubitemid 44657421)
15. + dendritic cells during infection with intracellular pathogens Immunol Lett 114 2007 66 72 (Pubitemid 350180095)
16. + dendritic cells are required for efficient entry of Listeria monocytogenes into the spleen Immunity 25 2006 619 630 (Pubitemid 44529037)
17. S. Jung, D. Unutmaz, P. Wong In vivo depletion of CD11c(+) dendritic cells abrogates priming of CD8(+) T cells by exogenous cell-associated antigens Immunity 17 2002 211
18. D. Kapadia, A. Sadikovic, Y. Vanloubbeeck, D. Brockstedt, L. Fong Interplay between CD8alpha dendritic cells and monocytes in response to Listeria monocytogenes infection attenuates T cell responses PLoS One 6 2011 e19376
19. L.M. Mitchell, K.L. Brzoza-Lewis, C.J. Henry, J.M. Grayson, M.M. Westcott, E.M. Hiltbold Distinct responses of splenic dendritic cell subsets to infection with Listeria monocytogenes: maturation phenotype, level of infection, and T cell priming capacity ex vivo Cell Immunol 268 2011 79 86
20. J.C. Waite, I. Leiner, P. Lauer Dynamic imaging of the effector immune response to listeria infection in vivo PLoS Pathog 7 2011 e1001326
21. L.A. O'Neill How Toll-like receptors signal: what we know and what we don't know Curr Opin Immunol 18 2006 3 9 (Pubitemid 43049641)
22. S.C. Corr, L.A. O'Neill Listeria monocytogenes infection in the face of innate immunity Cell Microbiol 11 2009 703 709
23. D.A. Portnoy, V. Auerbuch, I.J. Glomski The cell biology of Listeria monocytogenes infection: the intersection of bacterial pathogenesis and cell-mediated immunity J Cell Biol 158 2002 409 414 (Pubitemid 34851698)
24. M. O'Riordan, C.H. Yi, R. Gonzales, K.D. Lee, D.A. Portnoy Innate recognition of bacteria by a macrophage cytosolic surveillance pathway Proc Natl Acad Sci U S A 99 2002 13861 13866 (Pubitemid 35215471)
25. J.H. Leber, G.T. Crimmins, S. Raghavan, N.P. Meyer-Morse, J.S. Cox, D.A. Portnoy Distinct TLR- and NLR-mediated transcriptional responses to an intracellular pathogen PLoS Pathog 4 2008 e6
26. K.S. Bahjat, N. Meyer-Morse, E.E. Lemmens Suppression of cell-mediated immunity following recognition of phagosome-confined bacteria PLoS Pathog 5 2009 e1000568
27. E.G. Pamer Immune responses to Listeria monocytogenes Nat Rev Immunol 4 2004 812 823 (Pubitemid 39336297)
28. J.A. Vazquez-Boland, M. Kuhn, P. Berche Listeria pathogenesis and molecular virulence determinants Clin Microbiol Rev 14 2001 584 640 (Pubitemid 32642752)
29. A.T. Reinicke, K.D. Omilusik, G. Basha, W.A. Jefferies Dendritic cell cross-priming is essential for immune responses to Listeria monocytogenes PLoS One 4 2009 e7210
30. H. Shen, M.K. Slifka, M. Matloubian, E.R. Jensen, R. Ahmed, J.F. Miller Recombinant Listeria monocytogenes as a live vaccine vehicle for the induction of protective anti-viral cell-mediated immunity Proc Natl Acad Sci U S A 92 1995 3987 3991
31. D.G. Brockstedt, M.A. Giedlin, M.L. Leong Listeria-based cancer vaccines that segregate immunogenicity from toxicity Proc Natl Acad Sci U S A 101 2004 13832 13837 (Pubitemid 39298493)
32. H. Starks, K.W. Bruhn, H. Shen Listeria monocytogenes as a vaccine vector: virulence attenuation or existing antivector immunity does not diminish therapeutic efficacy J Immunol 173 2004 420 427 (Pubitemid 38797368)
33. G.R. Gunn, A. Zubair, C. Peters, Z.K. Pan, T.C. Wu, Y. Paterson Two Listeria monocytogenes vaccine vectors that express different molecular forms of human papilloma virus-16 (HPV-16) E7 induce qualitatively different T cell immunity that correlates with their ability to induce regression of established tumors immortalized by HPV-16 J Immunol 167 2001 6471 6479 (Pubitemid 33081581)
34. Z.K. Pan, G. Ikonomidis, A. Lazenby, D. Pardoll, Y. Paterson A recombinant Listeria monocytogenes vaccine expressing a model tumour antigen protects mice against lethal tumour cell challenge and causes regression of established tumours Nat Med 1 1995 471 477
35. L.M. Liau, E.R. Jensen, T.J. Kremen Tumor immunity within the central nervous system stimulated by recombinant Listeria monocytogenes vaccination Cancer Res 62 2002 2287 2293 (Pubitemid 34411706)
36. + T cells in the spleen and gut-associated lymphoid tissue by parenteral or mucosal immunization with recombinant Listeria monocytogenes HIV Gag J Immunol 170 2003 5176 5187 (Pubitemid 36554750)
37. K.S. Bahjat, R.A. Prell, H.E. Allen Activation of immature hepatic NK cells as immunotherapy for liver metastatic disease J Immunol 179 2007 7376 7384
38. M.M. Seavey, Y. Paterson Anti-Angiogenesis immunotherapy induces epitope spreading to Her-2/neu resulting in breast tumor immunoediting Breast Cancer (London) 1 2009 19 30
39. E.R. Jensen, R. Selvakumar, H. Shen, R. Ahmed, F.O. Wettstein, J.F. Miller Recombinant Listeria monocytogenes vaccination eliminates papillomavirus-induced tumors and prevents papilloma formation from viral DNA J Virol 71 1997 8467 8474 (Pubitemid 27446427)
40. K. Yoshimura, A. Jain, H.E. Allen et al. Selective targeting of anti-tumor immune responses with engineered live-attenuated Listeria monocytogenes Cancer Res 66 2006 1096 1104 (Pubitemid 43165978)
41. G.R. Gunn, A. Zubair, C. Peters, Z.-K. Pan, T.-C. Wu, Y. Paterson Two Listeria monocytogenes vaccine vectors that express different molecular forms of human papilloma virus-16 (HPV-16) E7 induce qualitatively different T cell immunity that correlates with their ability to induce regression of established tumors Immortalized by HPV-16 J Immunol 167 2001 6471 6479 (Pubitemid 33081581)
42. L.M. Liau, E.R. Jensen, T. Kremen Tumor immunity within the central nervous system stimulated by recombinant Listeria monocytogenes vaccination Cancer Res 62 2002 2287 2293 (Pubitemid 34411706)
43. N. Craft, K.W. Bruhn, B.D. Nguyen The TLR7 agonist imiquimod enhances the anti-melanoma effects of a recombinant Listeria monocytogenes vaccine J Immunol 175 2005 1983 1990 (Pubitemid 41023106)
44. P. Lauer, M.Y. Chow, M.J. Loessner, D.A. Portnoy, R. Calendar Construction, characterization, and use of two Listeria monocytogenes site-specific phage integration vectors J Bacteriol 184 2002 4177 4186 (Pubitemid 34774298)
45. A. Kolb-Maurer, S. Pilgrim, E. Kampgen Antibodies against listerial protein 60 act as an opsonin for phagocytosis of Listeria monocytogenes by human dendritic cells Infect Immun 69 2001 3100 3109 (Pubitemid 32332205)
46. M.L. Leong, J. Hampl, W. Liu Impact of pre-existing vector-specific immunity on vaccine potency: characterization of Listeria monocytogenes-specific humoral and cellular immunity in humans and modeling studies in mice using recombinant vaccines Infect Immun 77 2009 3958 3968
47. J.B. Whitney, S. Mirshahidi, S.Y. Lim et al. Prior exposure to an attenuated Listeria vaccine does not reduce immunogenicity: pre-clinical assessment of the efficacy of a Listeria vaccine in the induction of immune responses against HIV J Immune Based Ther Vaccines 9 2011 2
48. J.M. Farber, W.H. Ross, J. Harwig Health risk assessment of Listeria monocytogenes in Canada Int J Food Microbiol 30 1996 145 156 (Pubitemid 26258092)
49. J.M. Farber, P.I. Peterkin Listeria monocytogenes, a food-borne pathogen Microbiol Rev 55 1991 476 511 (Pubitemid 21895164)
50. J.C. Low, W. Donachie A review of Listeria monocytogenes and listeriosis Vet J 153 1997 9 29 (Pubitemid 127702992)
51. B. Lorber Listeriosis Clin Infect Dis 24 1997 1 9
52. D.G. Brockstedt, T.W. Dubensky Promises and challenges for the development of Listeria monocytogenes-based immunotherapies Expert Rev Vaccines 7 2008 1069 1084
53. L.G. Tilney, D.A. Portnoy Actin filaments and the growth, movement, and spread of the intracellular bacterial parasite, Listeria monocytogenes J Cell Biol 109 1989 1597 1607
54. + T lymphocytes by an attenuated Listeria monocytogenes actA mutant Int Immunol 4 1992 1413 1418 (Pubitemid 23005959)
55. H. Angelakopoulos, K. Loock, D. Sisul, E. Jensen, J.F. Miller, E.L. Hohmann Safety and shedding of an attenuated strain of Listeria monocytogenes with a deletion of actA/plcB in adult volunteers: a dose escalation study of oral inoculation Infect Immun 70 2002 3592 3601 (Pubitemid 34665997)
56. P. Cossart, J. Pizarro-Cerda, M. Lecuit Invasion of mammalian cells by Listeria monocytogenes: functional mimicry to subvert cellular functions Trends Cell Biol 13 2003 23 31 (Pubitemid 35453892)
57. J.A. Vazquez-Boland, M. Kuhn, P. Berche Listeria pathogenesis and molecular virulence determinants Clin Microbiol Rev 14 2001 584 640 (Pubitemid 32642752)
58. R. Singh, Y. Paterson Listeria monocytogenes as a vector for tumor-associated antigens for cancer immunotherapy Expert Rev Vaccines 5 2006 541 552 (Pubitemid 44627884)
59. R.J. Thompson, H.G. Bouwer, D.A. Portnoy, F.R. Frankel Pathogenicity and immunogenicity of a Listeria monocytogenes strain that requires D-alanine for growth Infect Immun 66 1998 3552 3561 (Pubitemid 28347808)
60. Z. Li, X. Zhao, D.E. Higgins, F.R. Frankel Conditional lethality yields a new vaccine strain of Listeria monocytogenes for the induction of cell-mediated immunity Infect Immun 73 2005 5065 5073 (Pubitemid 41105665)
61. Z. Li, M. Zhang, C. Zhou, X. Zhao, N. Iijima, F.R. Frankel Novel vaccination protocol with two live mucosal vectors elicits strong cell-mediated immunity in the vagina and protects against vaginal virus challenge J Immunol 180 2008 2504 2513
62. + T cell potency during bacterial infection Infect Immun 74 2006 6387 6397 (Pubitemid 44657421)
63. S.E. Hamilton, V.P. Badovinac, A. Khanolkar, J.T. Harty Listeriolysin O-deficient listeria monocytogenes as a vaccine delivery vehicle: antigen-specific CD8 T cell priming and protective immunity J Immunol 177 2006 4012 4020 (Pubitemid 44359934)
64. G. Lauvau, S. Vijh, P. Kong Priming of memory but not effector CD8 T cells by a killed bacterial vaccine Science 294 2001 1735 1739 (Pubitemid 33104848)
65. S.K. Datta, S. Okamoto, T. Hayashi Vaccination with irradiated Listeria induces protective T cell immunity Immunity 25 2006 143 152 (Pubitemid 44066835)
66. D.G. Brockstedt, K.S. Bahjat, M.A. Giedlin Killed but metabolically active microbes: a new vaccine paradigm for eliciting effector T-cell responses and protective immunity Nat Med 11 2005 853 860 (Pubitemid 41161117)
67. P. Lauer, B. Hanson, E.E. Lemmens Constitutive activation of the PrfA regulon enhances the potency of vaccines based on live-attenuated and killed but metabolically active Listeria monocytogenes strains Infect Immun 76 2008 3742 3753
68. P.V. Johnson, B.M. Blair, S. Zeller, C.N. Kotton, E.L. Hohmann Attenuated Listeria monocytogenes vaccine vectors expressing Influenza A nucleoprotein: preclinical evaluation and oral inoculation of volunteers Microbiol Immunol 55 2011 304 317
69. P.C. Maciag, S. Radulovic, J. Rothman The first clinical use of a live-attenuated Listeria monocytogenes vaccine: a phase I safety study of Lm-LLO-E7 in patients with advanced carcinoma of the cervix Vaccine 27 2009 3975 3983
70. R. Hassan, T. Bera, I. Pastan Mesothelin: a new target for immunotherapy Clin Cancer Res 10 2004 3937 3942 (Pubitemid 38812466)
71. D.T. Le, D. Brockstedt, R. Nir-Paz et al. A live-attenuated Listeria vaccine (ANZ-100) and a live-attenuated Listeria vaccine expressing mesothelin (CRS-207) for advanced cancers: phase 1 studies of safety and immune induction Clin Cancer Res 18 2011 1 11
72. + T cell immunity J Transl Med 8 2010 132
73. N.W. Schmidt, R.L. Podyminogin, N.S. Butler Memory CD8 T cell responses exceeding a large but definable threshold provide long-term immunity to malaria Proc Natl Acad Sci U S A 105 2008 14017 14022
74. N.L. Pham, L.L. Pewe, C.J. Fleenor et al. Exploiting cross-priming to generate protective CD8 T-cell immunity rapidly Proc Natl Acad Sci U S A 107 2010 12198 12203
75. J.D. Boyer, T.M. Robinson, P.C. Maciag DNA prime Listeria boost induces a cellular immune response to SIV antigens in the rhesus macaque model that is capable of limited suppression of SIV239 viral replication Virology 333 2005 88 101 (Pubitemid 40222193)
76. J. Fensterle, L. Grode, J. Hess, S.H. Kaufmann Effective DNA vaccination against listeriosis by prime/boost inoculation with the gene gun J Immunol 163 1999 4510 4518 (Pubitemid 29474521)
77. S. Quarmby, R.D. Hunter, S. Kumar Irradiation induced expression of CD31, ICAM-1 and VCAM-1 in human microvascular endothelial cells Anticancer Res 20 2000 3375 3381
78. M. Chakraborty, S.I. Abrams, K. Camphausen Irradiation of tumor cells up-regulates Fas and enhances CTL lytic activity and CTL adoptive immunotherapy J Immunol 170 2003 6338 6347 (Pubitemid 36682620)
79. + T-cell memory formation, function, and maintenance Proc Natl Acad Sci U S A 108 2011 266 271
80. + CTL epitopes with distinct functional profiles J Immunol 174 2005 2212 2219 (Pubitemid 40223967)
81. S. Radulovic, M. Brankovic-Magic, E. Malisic Therapeutic cancer vaccines in cervical cancer: phase I study of Lovaxin-C J Buon 14 Suppl 1 2009 S165 S168